Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
9.75
+0.35 (3.72%)
At close: Dec 20, 2024, 4:00 PM
9.24
-0.51 (-5.23%)
After-hours: Dec 20, 2024, 7:00 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $10.75 million as of December 20, 2024. Its market cap has decreased by -84.80% in one year.
Market Cap
10.75M
Enterprise Value
-10.46M
1-Year Change
-84.80%
Ranking
Category
Stock Price
$9.75
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $10.75M, a decrease of -91.70%. That is a compound annual growth rate of -55.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyra Therapeutics | 11.29M |
| Immuron | 11.19M |
| PharmaCyte Biotech | 11.15M |
| Jaguar Health | 11.04M |
| Relmada Therapeutics | 10.88M |
| Zhongchao | 10.64M |
| BioRestorative Therapies | 10.48M |
| Ensysce Biosciences | 10.45M |